
Redefining Excellence in Bioabsorbable Medical Devices
Groundbreaking Research
After 15 years of groundbreaking research, Professor Andrew Dove – a world leader in bioabsorbable polymer chemistry – has developed 4Degra®, a patented, game-changing implantable medical polymer.
4D is focused on two critical areas of innovation designed to improve surgical outcomes and enhance patient quality of life worldwide.
Biomaterials
Medical Devices
4D is utilising the benefits of 4Degra® to design and develop novel bioabsorbable medical devices that can be manufactured through 3D printing to a higher resolution at any dimensional scale. The goal is to improve surgical outcomes and leverage a technological breakthrough in a $6bn global marketplace.
Recent News
Ongoing FDA Application

Investor & Partnership
Opportunities
4D has a number of significant private investors backing material science and medical device development. The company is also actively pursuing partnerships with novel medical device and sales channel organisations.